Aug 6, 2026 02:46AM
Jul 22, 2026 04:05PM
May 6, 2026 04:23PM
May 6, 2026 04:05PM
Apr 21, 2026 04:05PM
Apr 1, 2026 04:05PM
Apr 1, 2026 04:05PM Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS)
Mar 6, 2026 02:13PM
Mar 5, 2026 11:55AM
Mar 4, 2026 04:27PM
Mar 4, 2026 04:05PM
Feb 18, 2026 04:05PM
Jan 13, 2026 07:06AM
Jan 13, 2026 07:05AM Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
Nov 6, 2025 04:27PM
Nov 6, 2025 04:05PM
Oct 23, 2025 04:05PM
Oct 17, 2025 07:01AM
Oct 17, 2025 07:00AM
Aug 7, 2025 04:21PM
Aug 7, 2025 04:05PM Sight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
Jul 24, 2025 04:05PM
May 8, 2025 04:20PM
May 8, 2025 04:05PM
Apr 24, 2025 04:05PM
Mar 5, 2025 04:12PM
Mar 5, 2025 04:05PM
Feb 19, 2025 04:05PM Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025
Jan 14, 2025 08:07AM
Jan 14, 2025 08:00AM
Nov 8, 2024 06:58AM
Nov 7, 2024 04:05PM
Nov 4, 2024 09:06AM
Oct 17, 2024 04:05PM
Aug 1, 2024 04:24PM Sight Sciences, Inc. (SGHT) Tops Q2 EPS by 5c, narrows guidance
Aug 1, 2024 04:05PM
Jul 18, 2024 04:05PM
May 2, 2024 04:50PM
May 2, 2024 04:05PM
Apr 18, 2024 04:05PM
Mar 7, 2024 04:20PM
Mar 7, 2024 04:05PM Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance
Feb 22, 2024 04:05PM
Feb 14, 2024 04:05PM
Jan 8, 2024 04:08PM
Jan 8, 2024 04:05PM
Nov 7, 2023 04:33PM
Nov 7, 2023 04:05PM
Oct 26, 2023 05:29PM Sight Sciences (SGHT) evaluating 2023 guidance due to "uncertain impact of reimbursement coverage for Surgical Glaucoma segment"
Oct 24, 2023 04:05PM

1,217,894 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All